Compounds > naltrexone

naltrexone and isradipine

naltrexone has been researched along with isradipine in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (50.00)	18.2507
2000's	5 (35.71)	29.6817
2010's	2 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chavkin, C; Gibbs, SM; Simmons, ML; Terman, GW	1
Cramer, CM; Hubbell, CL; Pabello, NG; Reid, LD	1
Boedeker, KL; Gardell, LR; Hubbell, CL; Liakos, TM; Reid, LD	1
Boedeker, KL; Cramer, CM; Gardell, LR; Harris, JR; Hubbell, CL; Reid, LD	1
Cramer, CM; Hubbell, CL; Reid, LD	1
Barringer, TM; Cavallaro, CA; Hubbell, CL; Mendez, JJ; Pabello, NG; Reid, LD	1
Ahmed, MS; Cemerikic, B; Zamah, R	1
Boedeker, KL; Douglass, AV; Hubbell, CL; Reid, LD; Reid, ML	1
Kosten, TR; McCance-Katz, FE; Oliveto, A; Petrakis, I; Singha, A; Sofuoglu, M	1

Reviews

1 review(s) available for naltrexone and isradipine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for naltrexone and isradipine

Article	Year
Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:4 Topics: Adult; Area Under Curve; Behavior, Addictive; Blood Pressure; Cocaine-Related Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Isradipine; Male; Naltrexone	2003

Other Studies

12 other study(ies) available for naltrexone and isradipine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells. Neuron, 1995, Volume: 14, Issue:6 Topics: Animals; Axons; Calcium Channel Blockers; Calcium Channels; Dendrites; Dynorphins; Guinea Pigs; Hippocampus; Isradipine; Long-Term Potentiation; Naltrexone; Nifedipine; omega-Conotoxin GVIA; Peptides; Receptors, Opioid, kappa	1995
Isradipine in combination with naltrexone as a medicine for treating cocaine abuse. Life sciences, 1997, Volume: 60, Issue:8 Topics: Animals; Calcium Channel Blockers; Cocaine; Drug Therapy, Combination; Electric Stimulation; Isradipine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Substance-Related Disorders	1997
Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Alcoholism, clinical and experimental research, 1997, Volume: 21, Issue:9 Topics: Alcohol Drinking; Alcoholic Beverages; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Ethanol; Isradipine; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Self Administration	1997
Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol. Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:2 Topics: Animals; Body Weight; Calcium Channel Blockers; Central Nervous System Depressants; Cocaine; Conditioning, Operant; Drinking; Drug Interactions; Ethanol; Isradipine; Male; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reward	1998
A combination of isradipine and naltrexone blocks cocaine's enhancement of a cocaine place preference. Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:4 Topics: Animals; Calcium Channel Blockers; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Isradipine; Male; Mental Recall; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Substance-Related Disorders	1998
Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone. Pharmacology, biochemistry, and behavior, 1998, Volume: 61, Issue:2 Topics: Analysis of Variance; Animals; Brain; Calcium Channel Blockers; Cocaine-Related Disorders; Drug Therapy, Combination; Electric Stimulation; Fluoxetine; Isradipine; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Valproic Acid	1998
Identification of L-type calcium channels associated with kappa opioid receptors in human placenta. Journal of molecular neuroscience : MN, 1998, Volume: 10, Issue:3 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Benzeneacetamides; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cell Membrane; Chorionic Gonadotropin; Chorionic Villi; Culture Techniques; Egtazic Acid; Female; Humans; Isradipine; Naltrexone; Nifedipine; Placenta; Pyrrolidines; Receptors, Opioid, kappa; Trophoblasts	1998
Research with rats germane to medication for alcoholism: consequences of noncompliance. Alcohol (Fayetteville, N.Y.), 2001, Volume: 24, Issue:3 Topics: Alcohol Drinking; Alcoholism; Animals; Calcium Channel Blockers; Drinking; Drug Therapy, Combination; Isradipine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Temperance	2001